within Pharmacolibrary.Drugs.D_Dermatologicals.D06A_AntibioticsForTopicalUse.D06AX13_Retapamulin;

model Retapamulin
  extends Pharmacolibrary.Drugs.ATC.D.D06AX13;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>D06AX13</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Retapamulin is a pleuromutilin antibiotic used topically for the treatment of superficial skin infections such as impetigo caused by susceptible strains of Staphylococcus aureus (excluding MRSA) and Streptococcus pyogenes. It is approved for use in several countries including the US and EU for this indication.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for healthy adult subjects after topical administration (intact skin, 1% ointment) as reported in public assessment reports and clinical summaries.</p><h4>References</h4><ol><li><p>Nagabushan, H (2010). Retapamulin: a novel topical antibiotic. <i>Indian journal of dermatology, venereology and leprology</i> 76(1) 77–79. DOI:<a href=&quot;https://doi.org/10.4103/0378-6323.58693&quot;>10.4103/0378-6323.58693</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/20061745/&quot;>https://pubmed.ncbi.nlm.nih.gov/20061745</a></p></li><li><p>Yang, LP, &amp; Keam, SJ (2008). Retapamulin: a review of its use in the management of impetigo and other uncomplicated superficial skin infections. <i>Drugs</i> 68(6) 855–873. DOI:<a href=&quot;https://doi.org/10.2165/00003495-200868060-00008&quot;>10.2165/00003495-200868060-00008</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18416589/&quot;>https://pubmed.ncbi.nlm.nih.gov/18416589</a></p></li><li><p>Yang, LP, &amp; Keam, SJ (2008). Spotlight on retapamulin in impetigo and other uncomplicated superficial skin infections. <i>American journal of clinical dermatology</i> 9(6) 411–413. DOI:<a href=&quot;https://doi.org/10.2165/0128071-200809060-00010&quot;>10.2165/0128071-200809060-00010</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18973410/&quot;>https://pubmed.ncbi.nlm.nih.gov/18973410</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Retapamulin;
